Science Explorer Back to mapMap
Discussion
Company · Tel Aviv · Israel

Neurim Pharmaceuticals (Israel)

Research works
42
▲ 63% vs 2018-21
Citations
2.7k
63.1 per fractional work
Top-10% rate
6.1%
all institutions 10.0%
Open access
32%
world 40%
International
44%
world 18%

Not ranked overall: Neurim Pharmaceuticals (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Neurim Pharmaceuticals (Israel) work in?

In all years, 52% of research at Neurim Pharmaceuticals (Israel) is in Life Sciences, 29% in Health Sciences. Its largest fields are Neuroscience (40%), Medicine (27%), Psychology (15%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 22 fractional works · 51.9% of its workNeuroscience: 17 fractional works · 39.9% of its workEndocrine and Autonomic Systems: 10 fractional works · 24.0% of its workCognitive Neuroscience: 5 fractional works · 12.6% of its workBiological Psychiatry: 0 fractional works · 1.1% of its workBehavioral Neuroscience: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 8.9% of its workMolecular Biology: 2 fractional works · 5.6% of its workCell Biology: 0 fractional works · 1.0% of its workBiophysics: 0 fractional works · 0.7% of its workCancer Research: 0 fractional works · 0.7% of its workBiochemistry: 0 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 1.6% of its workImmunology: 0 fractional works · 1.2% of its workMicrobiology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.0% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workAgronomy and Crop Science: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workHealth Sciences: 12 fractional works · 29.3% of its workMedicine: 12 fractional works · 27.4% of its workPhysiology: 3 fractional works · 7.2% of its workPsychiatry and Mental health: 2 fractional works · 3.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.1% of its workEpidemiology: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.8% of its workBiochemistry: 0 fractional works · 1.2% of its workOphthalmology: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 1.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workComplementary and alternative medicine: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.8% of its workInfectious Diseases: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workHealth Professions: 1 fractional works · 1.7% of its workGeneral Health Professions: 1 fractional works · 1.3% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.1% of its workSocial Sciences: 7 fractional works · 16.7% of its workPsychology: 6 fractional works · 15.4% of its workExperimental and Cognitive Psychology: 5 fractional works · 13.0% of its workClinical Psychology: 1 fractional works · 1.4% of its workSocial Psychology: 0 fractional works · 0.5% of its workApplied Psychology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 1.3% of its workHealth: 0 fractional works · 0.8% of its workEducation: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 2.2% of its workChemistry: 1 fractional works · 1.4% of its workOrganic Chemistry: 1 fractional works · 1.4% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.2% of its workALL ITS WORKNeurimPharmaceuticals…42fractional works, all years
Life Sciences52%Physical Sciences2%Health Sciences29%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Neuroscience1739.9%
    2. Biochemistry, Genetics and Molecular Biology48.9%
    3. Immunology and Microbiology11.6%
    4. Agricultural and Biological Sciences01.0%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Medicine1227.4%
    2. Health Professions11.7%
    3. Nursing00.1%
    1. Psychology615.4%
    2. Social Sciences11.3%
    1. Chemistry11.4%
    2. Engineering00.6%
    3. Environmental Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.52× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 10.98× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.11× its world share, 0 worksPharmacology, Toxico…Engineering: 0.42× its world share, 0 worksEngineeringHealth Professions: 2.97× its world share, 0 worksHealth ProfessionsMedicine: 1.56× its world share, 1 worksMedicinePsychology: 4.22× its world share, 0 worksPsychologySocial Sciences: 0.62× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.1×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics11.11×0 works
  2. Neuroscience10.98×1 works
  3. Psychology4.22×0 works
  4. Health Professions2.97×0 works
  5. Biochemistry, Genetics and Molecular Biology2.52×1 works
  6. Medicine1.56×1 works
  7. Social Sciences0.62×0 works
  8. Engineering0.42×0 works

Who are the top researchers at Neurim Pharmaceuticals (Israel)?

Ranked on the quality score, Tali Nir and Moshe Laudon lead among researchers whose main affiliation is Neurim Pharmaceuticals (Israel).

  1. 1 Tali Nir Israel · #358,874 worldwide 2.2k citations · 20 works
  2. 2 Moshe Laudon Israel · #1,176,634 worldwide 5.9k citations · 94 works
All ranked researchers at Neurim Pharmaceuticals (Israel)

What are the most cited papers from Neurim Pharmaceuticals (Israel)?

The most cited paper from Neurim Pharmaceuticals (Israel) is "New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation" (Nava Zisapel, 2018), with 868 citations. Next come "Improvement of sleep quality in elderly people by controlled-release melatonin" (478) and "Melatonin Replacement Therapy of Elderly Insomniacs" (348).

Most cited papers
#PaperReleasedCitations
1 New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation Nava Zisapel · British Journal of Pharmacology Open access 10 Jan 2018 868
2 Improvement of sleep quality in elderly people by controlled-release melatonin Doron Garfinkel, Moshe Laudon, Dina Nof et al. · The Lancet Aug 1995 478
3 Melatonin Replacement Therapy of Elderly Insomniacs Iris Haimov, Peretz Lavie, Moshe Laudon et al. · SLEEP Sep 1995 348
4 Sleep disorders and melatonin rhythms in elderly people Iris Haimov, Moshe Laudon, Nava Zisapel et al. · BMJ Open access 16 Jul 1994 316
5 Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder Paul Gringras, Tali Nir, John Breddy et al. · Journal of the American Academy of Child & Adolescent Psychiatry Open access 19 Sep 2017 312
All 60 most cited papers, with filters and sorting

Which keywords describe research at Neurim Pharmaceuticals (Israel)?

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Metabolism, Retinal Ganglion Cells, Health Effects, Circadian Rhythms, Circadian Clock, Melatonin and Meta-Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Oxidative Stress14▲ 17×12 topics
  2. Health Effects10▲ 40×2 topics
  3. Metabolism10▲ 37×3 topics
  4. Retinal Ganglion Cells10▲ 179×2 topics
  5. Circadian Rhythms10▲ 279×2 topics
  6. Circadian Clock10▲ 556×1 topic
  7. Melatonin10▲ 556×1 topic
  8. Epidemiology7▲ 4.0×9 topics
  9. Health Consequences5▲ 68×2 topics
  10. Meta-Analysis5▲ 23×2 topics
  11. Cognitive Behavioral Therapy5▲ 162×2 topics
  12. Insomnia5▲ 267×1 topic
  13. Sleep Duration5▲ 292×1 topic
  14. Memory5▲ 43×2 topics
  15. Consolidation5▲ 265×1 topic
  16. Sleep5▲ 265×1 topic
  17. Neurodegeneration2▲ 15×5 topics
  18. Inflammation2▲ 1.67×9 topics
  19. Neuroinflammation2▲ 15×3 topics
  20. Mitochondrial Dysfunction1▲ 9.4×4 topics
  21. Metabolic Syndrome1▲ 3.6×5 topics
  22. Depression1▲ 3.6×5 topics
  23. Insulin Resistance1▲ 5.8×3 topics
  24. Antioxidant1▲ 3.6×3 topics

Which research topics does Neurim Pharmaceuticals (Israel) publish most on?

By volume in 2022-now: Grief, Bereavement, and Mental Health, Employment and Welfare Studies, Health disparities and outcomes and Motor Control and Adaptation.

  1. 1 Grief, Bereavement, and Mental Health Clinical Psychology 0 works
  2. 2 Employment and Welfare Studies General Health Professions 0 works
  3. 3 Health disparities and outcomes Health 0 works
  4. 4 Motor Control and Adaptation Cognitive Neuroscience 0 works
  5. 5 Pain Mechanisms and Treatments Physiology 0 works
  6. 6 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  7. 7 Plant-based Medicinal Research Pharmacology 0 works
  8. 8 Advanced Neuroimaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Cancer Treatment and Pharmacology Oncology 0 works
  10. 10 Circadian rhythm and melatonin Endocrine and Autonomic Systems 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.0%not open68.0%

World: 40% of research is openly available.

with international co-authors44.0%domestic only56.0%

World: 18% is written across borders.

How has Neurim Pharmaceuticals (Israel)'s research output changed?

Output in 2022-2025 was 63% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Neurim Pharmaceuticals (Israel) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.00020%0.00040%Neurim Pharmaceuticals (Israel)0.000048% in 202519801990200020102020

Fractional works of Neurim Pharmaceuticals (Israel) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tel Aviv

All research institutions in Tel Aviv

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Neurim Pharmaceuticals (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.